3Scott EW,Thalacker AJ.Diagnosis and treatment of thyroid myopathy[J].Ophthalmology,1981,88:493-498.
4Bartalena L,Pinchera A,Marcocci C.Management of Graves ophthalmopathy Reality and perspective[J].Endocr Rev,2000,21(2):168-199.
二级参考文献9
1Werner SC. Modification of theclassification of the changes of Graves′disease: recommendations of the ad hoc committeeof the American thyroid association. J Clin. Endocr. Metab. 1977. 44:203.
2George B.Bartley, Diagnostic Criteria for Graves′Ophthalmopathy, American Journalof Ophthalmology, 119:792.
3John FS.Ultrasound in early thyroid orbitopathy. Arch Ophthalmol, 1980, 98:277.
4Robert A. Nugent, Graves Orbitopathy: Correlation of CT and clinical findings.Radiology, 1990, 177:675.
5Trokel SL, Jakobiec FA. Corelation of CT scanning and patholgic features ofophthalmic Graves′ disease. Ophthalmology, 1981, 88:553.
6Rootman J.Disease of orbit[M].Philadelphia:Lippincott,1988:119-142
7Mourits M Ph,Prummel M F,Wiersinga W M.Clinical activity score as a guide in the management of patient with Graves,ophthalmopathy[J].Clin Endocrinol,1997,47(1):9-14.
8Donaldson S S,Bagshaw M A,Kriss J P.Supervoltage orbital radiotherapy for Graves,ophthalmopathy[J].J Clin Endocrinol Metab,1973,37(2):276-285.
9吴中耀.现代眼肿瘤眼眶[M].北京:人民军医出版社,2002:464-497.
10Wiersinga WM, Prummel MF. Graves' ophthalmopathy: a rational approach tO treatment [ J ]. Trends Endocrinol Metab,2002,13(7) :280 - 287.
